Arterial spin labeling: Pathologically proven superiority over conventional MRI for detection of high-grade glioma progression after treatment

被引:16
|
作者
Nyberg, Eric [1 ]
Honce, Justin [1 ]
Kleinschmidt-DeMasters, Bette K. [2 ,3 ]
Shukri, Brian [1 ]
Kreidler, Sarah [4 ]
Nagae, Lidia [1 ]
机构
[1] Univ Colorado Hosp, Dept Radiol, 12605 E 16th Ave, Aurora, CO 80045 USA
[2] Univ Colorado Hosp, Dept Pathol, Aurora, CO USA
[3] Univ Colorado Hosp, Dept Neurol & Neurosurg, Aurora, CO USA
[4] Neptune & Co Inc, Los Alamos, NM USA
关键词
Arterial spin labeling; MR perfusion; glioblastoma; radiation necrosis; pseudoprogression;
D O I
10.1177/1971400916665375
中图分类号
R445 [影像诊断学];
学科分类号
100207 ;
摘要
Background: Standard of care for high-grade gliomas (HGGs) includes surgical debulking and adjuvant chemotherapy and radiation. Patients under treatment require frequent clinical and imaging monitoring for therapy modulation. Differentiating tumor progression from treatment-related changes can be challenging on conventional MRI, resulting in delayed recognition of tumor progression. Arterial spin labeling (ASL) may be more sensitive for tumor progression. Materials and methods: ASL and associated conventional MR images obtained in patients previously treated for HGGs and before biopsy or re-resection were reviewed by three neuroradiologists who were blinded to the histopathologic results. Regions of interest (ROIs) of greatest perfusion were chosen by consensus, and mirror-image contralateral ROIs were also placed. Sensitivity of ASL for tumor progression was compared with those of contrast-enhanced T1-weighted (T1W-CE) and fluid-attenuated inversion recovery (FLAIR) images using McNemar's test. We tested for an association between cerebral blood flow (CBF) and apparent diffusion correlation (ADC) using a Hotelling-Lawley trace. Finally, we used a Pearson's analysis to test for a correlation between CBF and percentage of tumor within each resection. Results: Twenty-two patients were studied. ASL demonstrated hyperperfusion in all cases with mean CBF ratio 3.37 (+/-1.71). T1W-CE and FLAIR images were positive in 15 (p = 0.0233) and 16 (p = 0.0412) cases, respectively. There was no association between ADC and CBF (p = 0.687). There was a correlation between CBF and percentage of tumor (p = 0.048). Conclusion: ASL may be more sensitive than conventional MR sequences for the detection of tumor progression in patients treated for HGGs.
引用
收藏
页码:377 / 383
页数:7
相关论文
共 50 条
  • [11] Diagnostic accuracy of arterial spin labeling in differentiating between primary central nervous system lymphoma and high-grade glioma: a systematic review and meta-analysis
    You, Guoliang
    Wu, Honggang
    Lei, Bo
    Wan, Xiaoqiang
    Chen, Shu
    Zheng, Niandong
    EXPERT REVIEW OF ANTICANCER THERAPY, 2022, 22 (07) : 763 - 771
  • [12] The value of arterial spin labelling (ASL) perfusion MRI in the assessment of post-treatment progression in adult glioma: A systematic review and meta-analysis.
    Alsulami, Tamadur A.
    Hyare, Harpreet
    Thomas, David L.
    Golay, Xavier
    NEURO-ONCOLOGY ADVANCES, 2023, 5 (01)
  • [13] Deep learning in the detection of high-grade glioma recurrence using multiple MRI sequences: A pilot study
    Bacchi, Stephen
    Zerner, Toby
    Dongas, John
    Asahina, Adon Toru
    Abou-Hamden, Amal
    Otto, Sophia
    Oakden-Rayner, Luke
    Patel, Sandy
    JOURNAL OF CLINICAL NEUROSCIENCE, 2019, 70 : 11 - 13
  • [14] The Differentiation between Progressive Disease and Treatment-Induced Effects with Perfusion-Weighted Arterial Spin-Labeling in High-Grade Gliomas
    Flies, Christina Maria
    Snijders, Tom Jan
    De Leeuw, Beverly Iendra
    van Maren, Emiel Alexander
    Kersten, Bart Jean Pieter
    Verhoeff, Joost Jacobus Cornelis
    De Vos, Filip Yves Francine
    Robe, Pierre Alain
    Hendrikse, Jeroen
    Dankbaar, Jan Willem
    AMERICAN JOURNAL OF NEURORADIOLOGY, 2024, 45 (07) : 920 - 926
  • [15] Perfusion imaging with arterial spin labeling (ASL)–MRI predicts malignant progression in low‑grade (WHO grade II) gliomas
    Christina M. Flies
    Tom J. Snijders
    Tom Van Seeters
    Marion Smits
    Filip Y. F. De Vos
    Jeroen Hendrikse
    Jan Willem Dankbaar
    Neuroradiology, 2021, 63 : 2023 - 2033
  • [16] Treatment Response and Prognosis Evaluation in High-Grade Glioma: An Imaging Review Based on MRI
    Zhou, Qing
    Xue, Caiqiang
    Ke, Xiaoai
    Zhou, Junlin
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2022, 56 (02) : 325 - 340
  • [17] Secondary Solid Malignancies After High-Grade Glioma Treatment in Pediatric Patients
    Karremann, Michael
    Hoffmann, Marion
    Benesch, Martin
    Kwiecien, Robert
    von Bueren, Andre O.
    Kramm, Christof M.
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2015, 32 (07) : 467 - 473
  • [18] High-grade glioma before and after treatment with radiation and Avastin: Initial observations
    Fischer, Ingeborg
    Cunliffe, Clare H.
    Bollo, Robert J.
    Raza, Shahzad
    Monoky, David
    Chiriboga, Luis
    Parker, Erik C.
    Golfinos, John G.
    Kelly, Patrick J.
    Knopp, Edmond A.
    Gruber, Michael L.
    Zagzag, David
    Narayana, Ashwatha
    NEURO-ONCOLOGY, 2008, 10 (05) : 700 - 708
  • [19] Bevacizumab for the treatment of high-grade glioma: an update after Phase Ill trials
    Khasraw, Mustafa
    Ameratunga, Malaka
    Grommes, Christian
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2014, 14 (05) : 729 - 740
  • [20] Perfusion imaging with arterial spin labeling (ASL)-MRI predicts malignant progression in low-grade (WHO grade II) gliomas
    Flies, Christina M.
    Snijders, Tom J.
    Van Seeters, Tom
    Smits, Marion
    De Vos, Filip Y. F.
    Hendrikse, Jeroen
    Dankbaar, Jan Willem
    NEURORADIOLOGY, 2021, 63 (12) : 2023 - 2033